Search results for "temi"

showing 10 items of 3194 documents

Correlation of Clinical and Immunologic Parameters of the Inflammatory Activity of Pulmonary Sarcoidosis

1991

The evaluation of activation markers such as T4/T8 ratio and HLA-DR expression of lymphocytes of bronchoalveolar lavage (L-BAL) is an important clinical approach for the staging of sarcoidosis. However, it is not known to what extent this is paralleled by an exaggerated lymphocyte function. We investigated the dependence of L-BAL activation markers on the production of interleukin-2 (IL-2) by L-BAL and on the soluble IL-2 receptor serum level (sIL-2R) in 116 patients with sarcoidosis. In none of the combinations tested was a correlation between the two groups of parameters found; r less than 0.5, upper 90% confidence limit of r less than 0.8. Interestingly, IL-2 production is independent of…

AdultLung DiseasesMalePulmonary and Respiratory MedicineSystemic diseaseSarcoidosisT-LymphocytesLymphocyteCD4-CD8 RatioCD4-CD8 RatioEnzyme-Linked Immunosorbent AssayInflammationLymphocyte ActivationHumansMedicineReceptormedicine.diagnostic_testbusiness.industryRespiratory diseaseReceptors Interleukin-2HLA-DR Antigensrespiratory systemmedicine.diseaserespiratory tract diseasesBronchoalveolar lavagemedicine.anatomical_structureImmunologyInterleukin-2FemaleSarcoidosismedicine.symptombusinessBronchoalveolar Lavage FluidAmerican Review of Respiratory Disease
researchProduct

HRCT and scleroderma: semiquantitative evaluation of lung damage and functional abnormalities.

2007

This study sought to validate the Warrick score in the assessment of lung involvement in systemic sclerosis (SSc) and correlate the results with functional abnormalities. In addition, we propose the use of high resolution computed tomography (HRCT) indices of alveolitis and fibrosis to discriminate between different stages of the disease.Thirty-one patients with SSc (16 with the diffuse form and 15 with the limited form) underwent functional and HRCT evaluations of the lung. The semiquantitative evaluation of radiological involvement, as proposed by Warrick, provides a score for each lesion based on the severity and the extent of the pulmonary damage. In addition to the total score, indices…

AdultLung DiseasesMalemedicine.medical_specialtyHigh-resolution computed tomographyGastroenterologySensitivity and SpecificitySeverity of Illness IndexLesionFibrosisDLCOScleroderma LimitedInternal medicineForced Expiratory VolumePulmonary fibrosisSeverity of illnessmedicineHumansRadiology Nuclear Medicine and imagingLung volumesAgedLungScleroderma Systemicmedicine.diagnostic_testbusiness.industryTotal Lung CapacityGeneral Medicinerespiratory systemMiddle Agedmedicine.diseaseFibrosisrespiratory tract diseasesRespiratory Function TestsPulmonary Alveolimedicine.anatomical_structureScleroderma DiffuseFemalemedicine.symptomlung scleroderma HRCTNuclear medicinebusinessTomography X-Ray ComputedLa Radiologia medica
researchProduct

Multicenter Phase I Study of Erdafitinib (JNJ-42756493), Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients with Advanced or Refractor…

2018

AbstractPurpose:Here, we report results of the first phase I study of erdafitinib, a potent, oral pan-FGFR inhibitor.Patients and Methods:Patients age ≥18 years with advanced solid tumors for which standard antineoplastic therapy was no longer effective were enrolled (NCT01703481). Parts 2 to 4 employed molecular screening for activating FGFR genomic alterations. In patients with such alterations, two selected doses/schedules identified during part 1 dose-escalation [9 mg once daily and 10 mg intermittently (7 days on/7 days off), as previously published (Tabernero JCO 2015;33:3401-8)] were tested.Results:The study included 187 patients. The most common treatment-related adverse events were…

AdultMale0301 basic medicineCancer Researchmedicine.medical_specialtyAdministration OralAntineoplastic AgentsDrug resistanceGastroenterologyYoung Adult03 medical and health sciencesHyperphosphatemia0302 clinical medicineRefractoryErdafitinibNeoplasmsQuinoxalinesInternal medicinemedicineHumansNeoplasmDosingAdverse effectProtein Kinase InhibitorsAgedNeoplasm StagingAged 80 and overbusiness.industryGenetic VariationMiddle AgedPrognosismedicine.diseaseReceptors Fibroblast Growth FactorTreatment Outcome030104 developmental biologyOncologyTolerabilityDrug Resistance Neoplasm030220 oncology & carcinogenesisRetreatmentPyrazolesFemalebusinessClinical Cancer Research
researchProduct

Contact dermatitis due to nickel allergy in patients suffering from non-celiac wheat sensitivity

2017

Background: Non‐celiac wheat sensitivity (NCWS) is a new clinical entity in the world of gluten‐related diseases. Nickel, the most frequent cause of contact allergy, can be found in wheat and results in systemic nickel allergy syndrome and mimics irritable bowel syndrome (IBS). Objective: To evaluate the frequency of contact dermatitis due to nickel allergy in NCWS patients diagnosed by a double‐blind placebo‐controlled(DBPC)challenge,and to identify the characteristics of NCWS patients with nickel allergy. Methods: We performed a prospective study of 60 patients (54 females, 6 males; mean age 34.1 ± 8.1 years) diagnosed with NCWS from December 2014 to November 2016; 80 age‐ and sex‐matched…

AdultMale0301 basic medicineNickel allergymedicine.medical_specialtyLetterSettore MED/09 - Medicina InternaNon-celiac wheat sensitivitynon-celiac wheat insensitivityNickel allergyWheat HypersensitivityArticlecutaneous symptoms03 medical and health sciences0302 clinical medicineDouble-Blind MethodNickelHypersensitivitymedicineCutaneous symptomHumansIngestionIn patientProspective StudiesProspective cohort studysystemic nickel allergy syndromeTriticumIrritable bowel syndromeNutrition and Dieteticsbusiness.industryCase-control studyPatch testnon‐celiac  wheat  sensitivity;  nickel  allergy;  cutaneous  symptoms;  irritable  bowel  syndromeCutaneous symptoms; Irritable bowel syndrome; Nickel allergy; Non-celiac wheat sensitivity; Food SciencePatch Testsmedicine.diseaseintradermal testingDermatologySurgeryIrritable bowel syndromenickel allergy ; non-celiac wheat sensitivity ; irritable bowel syndrome ; cutaneous symptoms030104 developmental biologyCase-Control StudiesDermatitis Allergic ContactFemale030211 gastroenterology & hepatologybusinessContact dermatitisFood Science
researchProduct

Programmed cell death protein 1 inhibitors in advanced cutaneous squamous cell carcinoma: real-world data of a retrospective, multicenter study

2020

Abstract Background Cutaneous squamous cell carcinoma (cSCC) is one of the most common malignancies of the skin. Even though most patients are sufficiently treated by surgical resection, some will eventually metastasize and need systemic therapy. Phase I and II studies have shown efficacy for programmed cell death protein 1 (PD-1) inhibitors, but cohort sizes are low and real-world data especially on long-term outcome are pending. Methods Patients from six German skin cancer centers treated with PD-1 inhibitors (pembrolizumab, nivolumab or cemiplimab) for advanced cSCC were retrospectively studied. Internal patient records were analyzed for clinical outcome including response, progression-f…

AdultMale0301 basic medicineOncologyCancer Researchmedicine.medical_specialtySkin Neoplasmsmedicine.medical_treatmentMedizinPembrolizumabSystemic therapy03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansImmune Checkpoint InhibitorsAgedRetrospective StudiesAged 80 and overL-Lactate Dehydrogenasebusiness.industryRetrospective cohort studyImmunotherapyMiddle Agedmedicine.disease3. Good health030104 developmental biologyOncology030220 oncology & carcinogenesisCohortCarcinoma Squamous CellFemaleNivolumabSkin cancerbusinessAdjuvantEuropean Journal of Cancer
researchProduct

Adult-onset Still’s disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers

2016

Background: Adult-onset Still's disease (AOSD) is rare inflammatory disease of unknown etiology that usually affects young adults. The more common clinical manifestations are spiking fevers, arthritis, evanescent rash, elevated liver enzymes, lymphadenopathy, hepatosplenomegaly, and serositis. The multi-visceral involvement of the disease and the different complications, such as macrophage activation syndrome, may strongly decrease the life expectancy of AOSD patients. Methods: This study aimed to identify the positive and negative features correlated with the outcome of patients. A retrospective analysis of AOSD patients prospectively admitted to three rheumatologic centers was performed t…

AdultMale0301 basic medicinemedicine.medical_specialtyPrognosiHepatosplenomegalyArthritisDiseaseAdult-onset Still's diseaseYoung Adult03 medical and health sciencesSystemic score0302 clinical medicineRetrospective StudieInternal medicinemedicineHumansYoung adultRetrospective StudiesAdult-onset Still’s diseaseMedicine(all)030203 arthritis & rheumatologyPrognostic factorbusiness.industryMedicine (all)BiomarkerGeneral MedicineMiddle AgedPrognosismedicine.diseaseRashSurgerySettore MED/16 - Reumatologia030104 developmental biologyMacrophage activation syndromeMacrophage activation syndromeEtiologyAdult-onset Still’s disease; Macrophage activation syndrome; Prognostic factor; Systemic scoreFemalemedicine.symptombusinessStill's Disease Adult-OnsetSerositisBiomarkersHumanResearch ArticleBMC Medicine
researchProduct

The relations of quality of life in patients with lupus erythematosus: Regression models versus qualitative comparative analysis

2019

Lupus erythematosus (LE) is an autoimmune disease that can have negative repercussions on the quality of life (QL) of those who suffer from it. The QL can be influenced by socio-demographic factors are related to the disease itself.To analyse the associative power of socio-demographic (age and sex) and medical variables (type of lupus, diagnostic time and symptomatically associated with lupus) on the QL in patients with lupus by comparing linear relations models and models based on comparative qualitative fuzzy analysis.This is a retrospective cross-sectional design.The sample consisted of 161 patients (88.4% female) diagnosed with LE between the ages of 18-66 years.Data were collected betw…

AdultMaleAdolescentDiseaseYoung Adult03 medical and health sciences0302 clinical medicineRisk groupsFuzzy LogicQuality of lifeHumansLupus Erythematosus SystemicMedicineIn patient030212 general & internal medicineQualitative ResearchGeneral NursingAgedRetrospective StudiesSystemic lupus erythematosusLupus erythematosus030504 nursingbusiness.industryQualitative comparative analysisRegression analysisMiddle Agedmedicine.diseaseCross-Sectional StudiesQuality of LifeRegression AnalysisFemale0305 other medical sciencebusinessClinical psychologyJournal of Advanced Nursing
researchProduct

Fatigue in SLE: diagnostic and pathogenic impact of anti-N-methyl-D-aspartate receptor (NMDAR) autoantibodies.

2019

ObjectivesWe explored the impact of circulating anti-N-methyl-D-aspartate receptor (NMDAR) antibodies on the severity of fatigue in patients with systemic lupus erythematosus (SLE).MethodsSerum samples of 426 patients with SLE were analysed for the presence of antibodies to the NR2 subunit of the NMDAR. In parallel, the severity of fatigue was determined according to the Fatigue Scale for Motor and Cognitive functions questionnaire. In a subgroup of patients with SLE, the hippocampal volume was correlated with the levels of anti-NR2 antibodies. Isolated immunoglobulin G from patients with anti-NR2 antibodies were used for murine immunohistochemical experiments and functional assays on neuro…

AdultMaleAdolescentImmunologyEnzyme-Linked Immunosorbent AssayAntibodies Monoclonal HumanizedReceptors N-Methyl-D-AspartateSeverity of Illness IndexGeneral Biochemistry Genetics and Molecular BiologyImmunoglobulin GCell Line03 medical and health sciencesYoung Adult0302 clinical medicineCerebrospinal fluidRheumatologymedicineImmunology and AllergyHumansLupus Erythematosus SystemicReceptorFatigueAgedAutoantibodies030203 arthritis & rheumatologySystemic lupus erythematosusbiologybusiness.industryAutoantibodyMiddle Agedmedicine.diseaseBelimumabImmunologybiology.proteinImmunohistochemistryFemaleAntibodybusiness030217 neurology & neurosurgeryImmunosuppressive Agentsmedicine.drugAnnals of the rheumatic diseases
researchProduct

Interferon-α Abrogates the Suppressive Effect of Apoptotic Cells on Dendritic Cells in anIn VitroModel of Systemic Lupus Erythematosus Pathogenesis

2013

Objective.An increased incidence of apoptotic cells and an increased activation of dendritic cells (DC) may be involved in the pathogenesis of systemic lupus erythematosus (SLE). We investigated the characteristics of apoptotic neutrophils and monocyte-derived DC of patients with SLE, their interaction, and the influence of autoantibodies and inflammatory cytokines on this interaction.Methods.Kinetics of neutrophil apoptosis and DC activation were studied by flow cytometry. To analyze the interaction of apoptotic cells with phagocytes, crossover coculture experiments were performed with DC from patients with SLE and apoptotic Jurkat T cells as well as with apoptotic neutrophils from patient…

AdultMaleAdolescentInterleukin-1betaImmunologyAlpha interferonApoptosisJurkat cellsProinflammatory cytokineJurkat CellsRheumatologyInterferonHumansLupus Erythematosus SystemicImmunology and AllergyMedicineAgedAutoantibodiesU937 cellbusiness.industryInterleukin-17Interferon-alphaDendritic CellsU937 CellsMiddle AgedApoptosisImmunologyFemaleCytokine secretionInterleukin 17businessmedicine.drugThe Journal of Rheumatology
researchProduct

Asymptomatic Leishmania infantum/chagasi infection in blood donors of western Sicily.

2007

The purpose of this study was to evaluate whether the risk of transfusion-transmitted visceral leishmaniasis was present in an area of western Sicily where the incidence of the disease is higher than the regional average. From May to December 2005, 1449 blood donors from Agrigento district (Sicily, Italy) were screened for the presence of anti-Leishmania antibodies by an indirect immunofluorescent antibody test (IFAT). Blood samples from IFAT-positive donors were examined by PCR to detect Leishmania DNA. Anti-Leishmania antibodies were found in 11 (0.75%) cases, among which Leishmania DNA was detected from four (36.4%). Particular techniques to inactivate different pathogens would be consid…

AdultMaleBlood transfusionSettore MED/17 - Malattie Infettivemedicine.medical_treatmentAntibodies ProtozoanBlood DonorsParasitemiaSettore MED/42 - Igiene Generale E Applicatalaw.inventionlawparasitic diseasesmedicineAnimalsHumansLeishmania infantumLeishmania blood donors asympthomatic infectionPolymerase chain reactionbiologyPublic Health Environmental and Occupational HealthGeneral MedicineLeishmania chagasiDNA ProtozoanMiddle Agedmedicine.diseasebiology.organism_classificationLeishmaniaInfectious DiseasesVisceral leishmaniasisItalyImmunologyCarrier Statebiology.proteinLeishmaniasis VisceralParasitologyFemaleAntibodyLeishmania infantumTransactions of the Royal Society of Tropical Medicine and Hygiene
researchProduct